DEI-03. COMPASSIONATE USE OF NOVEL AND TARGETED THERAPIES IN RELAPSED AND PROGRESSIVE MALIGNAT PEDIATRIC BRAIN TUMORS: EXPERIENCE OF A SINGLE INSTITUTION | Publicación